Subscribe to Newsletter

Manufacture


Manufacture Advanced Medicine

Time Machine

Step into a future where science fiction meets reality – the world of cell and gene therapies.

Manufacture Bioprocessing - Upstream & Downstream

Just – Evotec Biologics Expands in Europe

Find out more about a new continuous manufacturing facility opened by Just – Evotec Biologics in Toulouse, France.

Manufacture Small Molecules

eBook: Celebrating Small Molecule Drug Development

| Stephanie Vine

From AI, to hot-melt extrusion, continuous processing, generics, and more – check out our free eBook.

Manufacture Contract Manufacturing Services

Navigating Market Changes: Piramal Pharma's Growth and Key Industry Trends

| Rob Coker

Stu Needleman, Chief Commercial Officer at Piramal Pharma Solutions, discusses the Biosecure Act and other big trends shaking up the industry

Manufacture Profession

Awards Season at The Medicine Maker

| Rob Coker

At this time of year, we like to recognize the people and companies that have helped drive innovation and success – but we need your help.

Manufacture Advanced Medicine

Navigating the Challenges – and Opportunities -of Lentiviral Vectors

| Sponsored by Sartorius | 7 min read

Lentiviruses are growing in the advanced therapy landscape. Experts at Sartorius discuss the unique challenges that come with their production

Manufacture Bioprocessing - Upstream & Downstream

UK Government Bolsters Support for Life Sciences

| Rob Coker

What’s going on in UK life sciences? How the government is offering support to the sector and investing in talent.

Manufacture Contract Manufacturing Services

CDMOs and Small Molecule Challenges

| Elizabeth Hickman | 4 min read

How small molecule-focused CDMOs can help companies navigate the impact of the Inflation Reduction Act.

Manufacture Technology and Equipment

The Surge in Demand for Sterile Manufacturing

| Vincenza Pironti | 3 min read

How prefilled syringes, blow-fill-seal technology, and innovations in vials are transforming sterile manufacturing.

Manufacture Advanced Medicine

Next Generation CRISPR

| Venkata Indurthi | 3 min read

The pipeline of early-stage CRISPR therapeutics is huge, but advancing these innovations will require a multifaceted strategy.


Register to The Medicine Maker

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Medicine Maker magazine

Register